Abena Appiah-Kubi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

Abena Appiah-Kubi

Showing results (1-10 of 20) with videos related to

Pageof 2

Sort By:

Journal of Pediatric Hematology/Oncology|January 29, 2022

Documented Viral Illness at the Time of Splenic Sequestration Does Not Affect the Odds of Recurrence in Children With Sickle Cell DiseaseOmoyeni Clement, Joanna Fishbein, Abena Appiah-Kubi, et al.

British Journal of Haematology|June 1, 2019

Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell diseaseKristine Karkoska, Abena Appiah-Kubi, Joshua Rocker, et al.

Pediatric Blood & Cancer|February 22, 2020

A pilot study to screen for poor academic performance in children with sickle cell disease in the outpatient settingKristine Karkoska, Sibgha Zaheer, Victoria Chen, et al.

Pediatric Blood & Cancer|July 8, 2024

Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill recordsArlene Smaldone, Deepa Manwani, Banu Aygun, et al.

Pediatric Blood & Cancer|August 27, 2025

HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell DiseaseArlene Smaldone, Deepa Manwani, Banu Aygun, et al.

Blood Advances|September 16, 2021

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapyArushi Dhar, Tung Ming Leung, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|May 26, 2022

Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemicNancy S Green, Deepa Manwani, Kim Smith-Whitley, et al.

Blood Advances|June 4, 2026

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemiasSujit Sheth, Ashutosh Lal, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|May 12, 2018

Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlationSharon A Singh, Susmita Sarangi, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|February 6, 2024

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell diseaseNancy S Green, Deepa Manwani, Banu Aygun, et al.

Pageof 2

Search research articles

Showing results (1-10 of 20) with videos related to

Sort By:

Pageof 2

Journal of Pediatric Hematology/Oncology|January 29, 2022

Documented Viral Illness at the Time of Splenic Sequestration Does Not Affect the Odds of Recurrence in Children With Sickle Cell DiseaseOmoyeni Clement, Joanna Fishbein, Abena Appiah-Kubi, et al.

British Journal of Haematology|June 1, 2019

Management of vaso-occlusive episodes in the day hospital decreases admissions in children with sickle cell diseaseKristine Karkoska, Abena Appiah-Kubi, Joshua Rocker, et al.

Pediatric Blood & Cancer|February 22, 2020

A pilot study to screen for poor academic performance in children with sickle cell disease in the outpatient settingKristine Karkoska, Sibgha Zaheer, Victoria Chen, et al.

Pediatric Blood & Cancer|July 8, 2024

Assessing multilevel barriers to hydroxyurea adherence in youth with sickle cell disease using pharmacy-based refill recordsArlene Smaldone, Deepa Manwani, Banu Aygun, et al.

Pediatric Blood & Cancer|August 27, 2025

HABIT Efficacy Trial Intervention Improves Elements of General and Disease-Specific Quality of Life in Youth With Sickle Cell DiseaseArlene Smaldone, Deepa Manwani, Banu Aygun, et al.

Blood Advances|September 16, 2021

Longitudinal analysis of cardiac abnormalities in pediatric patients with sickle cell anemia and effect of hydroxyurea therapyArushi Dhar, Tung Ming Leung, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|May 26, 2022

Mental health assessment of youth with sickle cell disease and their primary caregivers during the COVID-19 pandemicNancy S Green, Deepa Manwani, Kim Smith-Whitley, et al.

Blood Advances|June 4, 2026

Real-world safety profile of twice a day deferiprone in patients with thalassemia, sickle cell disease, or other anemiasSujit Sheth, Ashutosh Lal, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|May 12, 2018

Hb Adana (HBA2 or HBA1: c.179G > A) and alpha thalassemia: Genotype-phenotype correlationSharon A Singh, Susmita Sarangi, Abena Appiah-Kubi, et al.

Pediatric Blood & Cancer|February 6, 2024

Hydroxyurea Adherence for Personal Best in Sickle Cell Treatment (HABIT) efficacy trial: Community health worker support may increase hydroxyurea adherence of youth with sickle cell diseaseNancy S Green, Deepa Manwani, Banu Aygun, et al.

Pageof 2